Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Transtec Patch (96h vs 72h) in Healthy Volunteers
NCT03770234Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2004
- Primary completion
- May 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of buprenorphine in pain (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Area under the concentration-time curve from 48 to 72 hours and Area under the concentration-time curve from 72 to 96 hours. Started Apr 2004; status: completed.
02
Drugs
buprenorphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03770234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770234.